AmplifiDx develops the DX 100™ platform, a molecular point-of-care diagnostic device that utilizes advanced multiplex technology to deliver rapid and accurate test results for family and women's health. This device addresses the need for affordable and efficient diagnostics, enabling healthcare professionals and patients to obtain reliable results in under one minute with minimal hands-on time.
Funding
$2.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.



Founders
Product
Problem
Traditional diagnostic methods for family and women's health often require lab processing, resulting in delayed results and hindering timely clinical decision-making. Existing point-of-care solutions may lack the accuracy and multiplexing capabilities needed for comprehensive testing. This can lead to increased healthcare costs and suboptimal patient outcomes.
Solution
AmplifiDx offers the DX 100™ platform, a molecular point-of-care diagnostic device designed for rapid and accurate testing in family and women's health. The platform utilizes advanced multiplex technology to deliver results with minimal hands-on time, enabling test-to-treat strategies. By providing fast and reliable results, the DX 100™ platform aims to improve efficiency, affordability, and accuracy in diagnostics, ultimately leading to better health outcomes. The system is designed to be accessible, allowing healthcare professionals and patients to obtain the answers they need quickly and efficiently.
Target Audience
The primary target audience includes healthcare professionals and patients in family and women's health settings who require fast, accurate, and affordable diagnostic testing at the point of care.
Features
- Molecular point-of-care diagnostics for family and women’s health
- Rapid results in under one minute
- Less than one minute hands-on time
- Advanced multiplex technology capable of detecting up to 10 analytes
- Enables test-to-treat strategies